FR3122991B1 - CRASSULACEAN ACID METABOLISM PLANT EXTRACT FOR USE IN THE TREATMENT OF DYSMENORRHEA AND/OR PAIN RELATED TO MENSTRUAL SPASMS AND CRAMPS - Google Patents
CRASSULACEAN ACID METABOLISM PLANT EXTRACT FOR USE IN THE TREATMENT OF DYSMENORRHEA AND/OR PAIN RELATED TO MENSTRUAL SPASMS AND CRAMPS Download PDFInfo
- Publication number
- FR3122991B1 FR3122991B1 FR2105309A FR2105309A FR3122991B1 FR 3122991 B1 FR3122991 B1 FR 3122991B1 FR 2105309 A FR2105309 A FR 2105309A FR 2105309 A FR2105309 A FR 2105309A FR 3122991 B1 FR3122991 B1 FR 3122991B1
- Authority
- FR
- France
- Prior art keywords
- dysmenorrhea
- treatment
- acid metabolism
- cramps
- spasms
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/33—Cactaceae (Cactus family), e.g. pricklypear or Cereus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Botany (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Reproductive Health (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
EXTRAIT DE VEGETAL A METABOLISME ACIDE CRASSULACEEN pour utilisation dans le traitement de la dysménorrhée et/ou des douleurs liées aux spasmes et crampes menstruels La présente invention concerne un extrait d’au moins un végétal à métabolisme acide crassulacéen pour utilisation dans le traitement de la dysménorrhée. La présente invention concerne également une composition pharmaceutique comprenant un extrait selon l’invention.PLANT EXTRACT WITH CRASSULACEAN ACID METABOLISM for use in the treatment of dysmenorrhea and/or pain linked to menstrual spasms and cramps. The present invention relates to an extract of at least one plant with crassulacean acid metabolism for use in the treatment of dysmenorrhea . The present invention also relates to a pharmaceutical composition comprising an extract according to the invention.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR2105309A FR3122991B1 (en) | 2021-05-20 | 2021-05-20 | CRASSULACEAN ACID METABOLISM PLANT EXTRACT FOR USE IN THE TREATMENT OF DYSMENORRHEA AND/OR PAIN RELATED TO MENSTRUAL SPASMS AND CRAMPS |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR2105309A FR3122991B1 (en) | 2021-05-20 | 2021-05-20 | CRASSULACEAN ACID METABOLISM PLANT EXTRACT FOR USE IN THE TREATMENT OF DYSMENORRHEA AND/OR PAIN RELATED TO MENSTRUAL SPASMS AND CRAMPS |
| FR2105309 | 2021-05-20 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR3122991A1 FR3122991A1 (en) | 2022-11-25 |
| FR3122991B1 true FR3122991B1 (en) | 2024-05-31 |
Family
ID=78332825
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR2105309A Active FR3122991B1 (en) | 2021-05-20 | 2021-05-20 | CRASSULACEAN ACID METABOLISM PLANT EXTRACT FOR USE IN THE TREATMENT OF DYSMENORRHEA AND/OR PAIN RELATED TO MENSTRUAL SPASMS AND CRAMPS |
Country Status (1)
| Country | Link |
|---|---|
| FR (1) | FR3122991B1 (en) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2757863B1 (en) | 1996-12-27 | 1999-03-26 | Inovat Sarl | NOVEL BIOLOGICALLY ACTIVE SUBSTANCES, PROCESS FOR OBTAINING SAME AND COMPOSITIONS CONTAINING SAME |
| WO2002005830A2 (en) * | 2000-07-14 | 2002-01-24 | Shantaram Govind Kane | Extracts from crassulacean acid metabolism (cam) mechanism plants and uses thereof |
| EP1932531A1 (en) | 2006-12-11 | 2008-06-18 | Finzelberg GmbH & Co. KG | Special extract and its use to inhibit the decomposition of cyclical guanosinmonophosphate (cGMP) |
| KR101808944B1 (en) * | 2016-04-27 | 2017-12-13 | 충북대학교 산학협력단 | Composition for preventing and treating dysmenorrhea and premature labor comprising non-polar solvent subfraction from Zingiber officinale extract |
| US11986506B2 (en) | 2017-01-20 | 2024-05-21 | Laila Nutraceuticals | Dietary supplements for inhibiting PDE5 and increasing cGMP levels |
-
2021
- 2021-05-20 FR FR2105309A patent/FR3122991B1/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| FR3122991A1 (en) | 2022-11-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA52492B1 (en) | RIP1 INHIBITORY COMPOUNDS, METHODS OF PREPARATION AND USE THEREOF | |
| MA44312A (en) | ANTIBODIES AND THEIR METHODS OF USE | |
| Maralani et al. | Antioxidant and cytoprotective effects of L-Serine on human endothelial cells | |
| MA41072A1 (en) | New pyoverine and pyochelin specific proteins | |
| MA30047B1 (en) | PROCESS FOR TREATING JOINT LESION | |
| MA29615B1 (en) | PREPARATIONS AND METHODS FOR DIAGNOSING AND TREATING A TUMOR | |
| MA34726B1 (en) | PREVENTING SIDE EFFECTS CAUSED BY SPECIFIC CD3 LINKAGE DOMAINS | |
| MA33768B1 (en) | Trichlorethylene | |
| TNSN98211A1 (en) | COMBINATION OF AN ALDOSE-REDUCTASE INHIBITOR AND A GLYCOGENE-PHOSPHORYLASE INHIBITOR, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME | |
| TNSN99133A1 (en) | IMPROVED PROCESS FOR THE PREPARATION OF SCHIFF BASES AND PRODUCTS THUS OBTAINED | |
| MA46611B1 (en) | Combination therapies including imidazopyrazinones for the treatment of psychiatric and / or cognitive disorders | |
| MA34917B1 (en) | SUBSTITUTED 3-HETEROAROYLAMINO-PROPIONIC ACID DERIVATIVES AND THEIR USE AS PHARMACEUTICAL COMPOUNDS | |
| FR3122991B1 (en) | CRASSULACEAN ACID METABOLISM PLANT EXTRACT FOR USE IN THE TREATMENT OF DYSMENORRHEA AND/OR PAIN RELATED TO MENSTRUAL SPASMS AND CRAMPS | |
| MA29784B1 (en) | COMBINATIONS CONTAINING DMXAA TO TREAT CANCER | |
| MA31130B1 (en) | COMBINATION COMPRISING IRON CHELATANT AND ANTINEOPLASTIC AGENT AND APPLICATIONS THEREOF | |
| FR3103106B1 (en) | Aqueous liquid extract of Spirulina for the prevention and/or treatment of chemo-induced peripheral neuropathies and their corresponding symptoms, composition and use. | |
| FR3059236B1 (en) | EXTRACTS FROM PLANTS OF THE GENUS TAGETES AND USES THEREOF | |
| FR3100128B1 (en) | Pharmaceutical composition for inhibiting HIV infectivity, treating acquired immunodeficiency syndrome (AIDS) and its complications | |
| MA38699A1 (en) | Oral formulation for the treatment of cardiovascular diseases | |
| FR3122990B1 (en) | Plant extract with crassulacean acid metabolism for use in the treatment of erectile dysfunction | |
| BE1028576B1 (en) | Composition comprising at least one boswellic acid and/or at least one plant extract comprising at least one boswellic acid for topical use in the treatment of inflammatory skin diseases | |
| MA27690A1 (en) | ANDROGENIC PHARMACEUTICAL COMPOSITION AND METHOD FOR THE TREATMENT OF DEPRESSION. | |
| FR3114504B1 (en) | Composition comprising a glycolipid and a salicyclic acid derivative | |
| CA3247001A1 (en) | Antibodies against human siglec-9 and use thereof for immunotherapy | |
| Gazulla et al. | Two-year follow-up of docosahexaenoic acid supplementation in spinocerebellar ataxia type 38 (SCA38) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PLFP | Fee payment |
Year of fee payment: 2 |
|
| PLSC | Publication of the preliminary search report |
Effective date: 20221125 |
|
| PLFP | Fee payment |
Year of fee payment: 3 |
|
| PLFP | Fee payment |
Year of fee payment: 4 |
|
| PLFP | Fee payment |
Year of fee payment: 5 |